Christopher Jorgensen
Direktor/Vorstandsmitglied bei Vapogenix, Inc.
Aktive Positionen von Christopher Jorgensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - | - |
Pamoja Capital SA
Pamoja Capital SA Investment ManagersFinance Pamoja Capital SA operates as a private investment firm. It specializes in long-term, socially-responsible, global investments across a number of industry sectors, including education, life sciences, information technology, real estate and media and communications. The firm's investments span all stages of corporate growth, including seed and growth capital. It seeks capital appreciation through long-term investments and emphasis on investing in businesses with sustainable cash flow. The company was founded by John H. McCall MacBain in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
Karriereverlauf von Christopher Jorgensen
Ausbildung von Christopher Jorgensen
Woodrow Wilson School of Public & International Affairs | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Schweiz | 2 |
Operativ
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Services | 2 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Health Services |
Pamoja Capital SA
Pamoja Capital SA Investment ManagersFinance Pamoja Capital SA operates as a private investment firm. It specializes in long-term, socially-responsible, global investments across a number of industry sectors, including education, life sciences, information technology, real estate and media and communications. The firm's investments span all stages of corporate growth, including seed and growth capital. It seeks capital appreciation through long-term investments and emphasis on investing in businesses with sustainable cash flow. The company was founded by John H. McCall MacBain in 2006 and is headquartered in Geneva, Switzerland. | Finance |
- Börse
- Insiders
- Christopher Jorgensen
- Erfahrung